Revestive® (teduglutide) receives European marketing authorization for the treatment of adults with Short Bowel Syndrome (SBS)
The European Commission has granted European market authorization for the…
4 September 2012 | By F T I Consulting
The European Commission has granted European market authorization for the medicinal product teduglutide...